Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2001

View Archived Issues

Renewed focus on oncology products at Transgene

AltaRex reports 2000 update

Clinical data reported for an optimized Theratope vaccine formulation

Pharmagenesis establishes development teams for two cancer treatment drug candidates

Cypress Bioscience and Georgetown collaborate on treatment for fibromyalgia syndrome

FDA supports Vical's Allovectin-7 clinical development program

Apomate begins phase II evaluation for cancer detection

Genelabs presents DNA-binding antifungal agents

Aventis creates new Gencell entity and restructures alliance with Introgen

Herceptin receives Japanese approval for treatment of metastatic breast cancer

Carboxypeptidase A-activated antifolate prodrug identified by Dana-Farber

DuPont identifies small-molecule TACE inhibitors for inflammation, autoimmune diseases

Orphan drug designation granted in Europe for Trisenox

Traditional Chinese medicinal formulation useful for alleviating toxicity of chemotherapy

FDA approves Celltech's once-daily ADHD treatment

New topoisomerase I-interactive fluoroindolocarbazole presented by BMS at AACR meeting

Antisense approaches to diabetes discussed at ACS by Isis

Launch announced for Viadur for advanced prostate cancer

Ark Therapeutics obtains positive results in EG-009 phase I/IIa trial

GSK discusses discovery and SAR for new series of dual PPARgamma/PPARalpha activators

Sch-62373, a dual NK1/NK2 antagonist from a series of 2-phenylpiperazines

New TAP anticancer therapeutic CPI-0004Na: design and synthesis reported this week

Sankyo presents new tachykinin antagonists and potential uses

Novel naturally produced compound is selective against H. pylori

Muscarinic M3-selective antagonists designed at Banyu

Thiophene NPY Y5 receptor ligands useful for eating and other disorders

Meiji Seika reports new series interacting with 5-HT4 receptors

Japanese patent covers preparation and use of beta3-adrenoceptor agonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...